Status
Completed
Phase
N/A
Study type
Observational
Enrollment
305
Sex
Women only
Ages
Ages 45 Years to 65 Years
Primary completion
2024-08-01
Last update
2025-01-01

What this trial studies

This cross-sectional study aimed to evaluate the relationship between the frequency and severity of postmenopausal symptoms in women aged 45-65 years and the level of compliance with the Mediterranean diet, and the main question it aimed to answer is: Do women with higher compliance with the Mediterranean diet have milder symptoms?

Conditions in scope

  • Menopausal Complaints

Interventions

  • Not specified in the public record.

Who can join

Women only · Ages 45 Years to 65 Years · Accepts healthy volunteers.

Inclusion criteria

  • Those who volunteered to participate in the study,

Exclusion criteria

  • Those with a diagnosed eating disorder,
  • Those using medication for obesity,
  • Those with a chronic metabolic disease that is not receiving treatment and whose values related to the disease are not regulated (pronounced hypo/hyperthyroidism, uncontrolled diabetes, etc.),
  • Those with a mental or physical condition that prevents communication (some neuropsychiatric diseases and mental retardation),
  • Those who do not understand and/or speak Turkish,
  • Those who do not give consent to participate in the study, •-Those who are currently using any hormonal supplements to prevent or reduce menopausal symptoms were excluded from the study.

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

CityState / RegionFacilitySite status
Istanbul Tuzla Marmara University- Tuzla Eğitim ASM Unknown

Status & timeline

  • Overall status: Completed
  • Study type: Observational
  • Phase: N/A
  • Start date: 2024-01-01
  • Primary completion: 2024-08-01
  • Last update posted: 2025-01-01
  • First posted: 2025-01-01

Lead sponsor: Marmara University Pendik Training and Research Hospital (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

  • Mediterranean diet adherence and menopausal symptoms association (Data collected at a single time point upon participants' enrollment.)
    Mediterranean diet adherence total score and menopausal rating scale total score were inversely and weakly correlated with each other (p\<0.01; r= -0.295).

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.

Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06755255 before contacting a site.

ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.